HCAQ vs. MHUA, VBIV, NERV, PAVM, BNTC, ORGS, ATIP, PMCB, HUGE, and KALA
Should you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Meihua International Medical Technologies (MHUA), VBI Vaccines (VBIV), Minerva Neurosciences (NERV), PAVmed (PAVM), Benitec Biopharma (BNTC), Orgenesis (ORGS), ATI Physical Therapy (ATIP), PharmaCyte Biotech (PMCB), FSD Pharma (HUGE), and KALA BIO (KALA). These companies are all part of the "medical" sector.
HealthCor Catalio Acquisition (NASDAQ:HCAQ) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.
Meihua International Medical Technologies has higher revenue and earnings than HealthCor Catalio Acquisition.
84.2% of HealthCor Catalio Acquisition shares are held by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are held by institutional investors. 66.6% of Meihua International Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Meihua International Medical Technologies had 4 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 4 mentions for Meihua International Medical Technologies and 0 mentions for HealthCor Catalio Acquisition. Meihua International Medical Technologies' average media sentiment score of 0.33 beat HealthCor Catalio Acquisition's score of 0.00 indicating that Meihua International Medical Technologies is being referred to more favorably in the news media.
HealthCor Catalio Acquisition and Meihua International Medical Technologies both received 0 outperform votes by MarketBeat users.
Summary
Meihua International Medical Technologies beats HealthCor Catalio Acquisition on 4 of the 5 factors compared between the two stocks.
Get HealthCor Catalio Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HCAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HealthCor Catalio Acquisition Competitors List
Related Companies and Tools
